Space research accelerates gene therapy for neurological disorders

Space research accelerates gene therapy for neurological disorders

Space Daily

Published

Los Angeles CA (SPX) Nov 22, 2024

Biotechnology startup Axonis Therapeutics has leveraged the unique microgravity environment of the International Space Station (ISS) to develop and test advanced neurological treatments. The company reprogrammed a harmless virus to deliver gene therapy directly to neurons, addressing conditions such as Alzheimer's, Parkinson's, and spinal cord injuries. Axonis used the ISS to create mature 3D hu

Full Article